Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berchuck

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Journal of Clinical Pathology|November 24, 1999
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutationsR P Zweemer, P A Shaw, R M Verheijen, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 16, 2005
Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancerA Alvarez Secord, E L Jones, C A Hahn, et al.
European Journal of Gynaecological Oncology|February 24, 2001
Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGOP Bösze, R C Bast, A Berchuck, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Identification of genes associated with ovarian cancer metastasis using microarray expression analysisJ M Lancaster, H K Dressman, J P Clarke, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignanciesA M Hussein, W P Petros, M Ross, et al.
Molecular Carcinogenesis|December 30, 1998
Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7qO van der Heijden, H C Chiu, T C Park, et al.
Nature Genetics|June 1, 1996
BRCA2 mutations in primary breast and ovarian cancersJ M Lancaster, R Wooster, J Mangion, et al.
British Journal of Cancer|September 10, 2009
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysisJ M Cunningham, R A Vierkant, T A Sellers, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
British Journal of Cancer|January 8, 2009
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association ConsortiumC L Pearce, A M Near, D J Van Den Berg, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Journal of Clinical Pathology|November 24, 1999
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutationsR P Zweemer, P A Shaw, R M Verheijen, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 16, 2005
Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancerA Alvarez Secord, E L Jones, C A Hahn, et al.
European Journal of Gynaecological Oncology|February 24, 2001
Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGOP Bösze, R C Bast, A Berchuck, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Identification of genes associated with ovarian cancer metastasis using microarray expression analysisJ M Lancaster, H K Dressman, J P Clarke, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignanciesA M Hussein, W P Petros, M Ross, et al.
Molecular Carcinogenesis|December 30, 1998
Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7qO van der Heijden, H C Chiu, T C Park, et al.
Nature Genetics|June 1, 1996
BRCA2 mutations in primary breast and ovarian cancersJ M Lancaster, R Wooster, J Mangion, et al.
British Journal of Cancer|September 10, 2009
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysisJ M Cunningham, R A Vierkant, T A Sellers, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
British Journal of Cancer|January 8, 2009
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association ConsortiumC L Pearce, A M Near, D J Van Den Berg, et al.
Pageof 20